AURIGENE DISCOVERY TECHNOLOGIES LIMITED

Company Introduction: Aurigene Discovery Technologies Limited

Aurigene Discovery Technologies Limited is an Indian biotechnology company based in Bengaluru, India. It primarily operates as a research and development (R&D) and manufacturing entity within the pharmaceutical and life sciences sector.

The company specializes in discovering and developing novel small molecule and peptide drugs, with a particular focus on therapeutic areas such as oncology and immunology. Aurigene conducts extensive research, pre-clinical development, and early clinical development of potential drug candidates, often partnering with global pharmaceutical companies. Its activities involve laboratory research, synthesis of compounds, and the production of drug candidates for further testing and development.

Nature of Business: Factory (Manufacturer)

Aurigene Discovery Technologies Limited is a factory or manufacturer. It engages in the creation, development, and production of drug candidates and related intellectual property, rather than merely trading existing products.

Aurigene Discovery Technologies Limited primarily produces and sells the following:

Drug Discovery and Development Services:

Integrated drug discovery services, including medicinal chemistry, in vitro and in vivo biology, ADME/PK (Absorption, Distribution, Metabolism, Excretion / Pharmacokinetics), and toxicology studies.

Preclinical development support.

Process chemistry and CMC (Chemistry, Manufacturing, and Controls) support for drug candidates.

Proprietary Drug Candidates (developed and typically licensed to other pharmaceutical companies for further clinical development and commercialization):

Oncology Drug Candidates:

Small molecule inhibitors targeting various cancer pathways, such as IRAK4 inhibitors and immune checkpoint inhibitors. Examples include molecules like CA-4948 (formerly AUR101) and CA-170 (formerly AUR001), which are licensed assets.

Inflammation and Autoimmune Disease Drug Candidates:

Small molecules aimed at modulating inflammatory and autoimmune pathways.

Neuroscience Drug Candidates:

Molecules under discovery for various neurological disorders.

Peptide Therapeutics:

Discovery and development of peptide-based drug candidates.